Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Pulmonary Hypertension, August 2017

Free Subscription


Abstracts

Retrieve all available abstracts of the following 80 articles:
HTML format


 

Single Articles

  1. KELLY LE, Ohlsson A, Shah PS
    Sildenafil for pulmonary hypertension in neonates.
    Cochrane Database Syst Rev. 2017;8:CD005494.
    Abstract    

    Abstract available

  2. JAWAD A, Tonelli AR, Chatburn RL, Wang X, et al
    Impact of Intrathoracic Pressure in the Assessment of Pulmonary Hypertension in Overweight Patients.
    Ann Am Thorac Soc. 2017 Aug 4. doi: 10.1513/AnnalsATS.201704.
    Abstract    



  3. SALEBY J, Bouzina H, Lundgren J, Radegran G, et al
    Angiogenic and inflammatory biomarkers in the differentiation of pulmonary hypertension.
    Scand Cardiovasc J. 2017 Aug 4:1-10. doi: 10.1080/14017431.2017.1359419.
    Abstract    

    Abstract available

  4. ULRICH S, Schneider SR, Bloch KE
    Effect of hypoxia and hyperoxia on exercise performance in healthy individuals and in patients with pulmonary hypertension: A systematic review.
    J Appl Physiol (1985). 2017 Aug 3:jap.00186.2017.
    Abstract    

    Abstract available

  5. HUANG X, Wu P, Huang F, Xu M, et al
    Baicalin attenuates chronic hypoxia-induced pulmonary hypertension via adenosine A2A receptor-induced SDF-1/CXCR4/PI3K/AKT signaling.
    J Biomed Sci. 2017;24:52.
    Abstract    

    Abstract available

  6. JANKOWICH M, Hebel R, Jantz J, Abbasi S, et al
    EXPRESS: Multispecialty Pulmonary Hypertension Clinic in the VA.
    Pulm Circ. 2017 Jan 1:2045893217726063. doi: 10.1177/2045893217726063.
    Abstract    



  7. SAITO M, Ohshima N, Matsui H, Hebisawa A, et al
    Sudden Death in a Patient with Pulmonary Veno-occlusive Disease (PVOD) and Severe Pulmonary Hypertension.
    Intern Med. 2017;56:2025-2031.
    Abstract    

    Abstract available

  8. CHEN CM, Lin W, Huang LT, Chou HC, et al
    Human mesenchymal stem cells ameliorate experimental pulmonary hypertension induced by maternal inflammation and neonatal hyperoxia in rats.
    Oncotarget. 2017 Jul 19. doi: 10.18632/oncotarget.19388.
    Abstract    

    Abstract available

  9. ZENG C, Liang B, Jiang R, Shi Y, et al
    Protein kinase C isozyme expression in right ventricular hypertrophy induced by pulmonary hypertension in chronically hypoxic rats.
    Mol Med Rep. 2017 Jul 27. doi: 10.3892/mmr.2017.7098.
    Abstract    

    Abstract available

  10. KUNWAR BK, Paddalwar S, Ghogare M
    Large Isolated Major Aortopulmonary Collateral Artery Causing Severe Pulmonary Hypertension in an Infant: A Rare and Challenging Diagnosis.
    J Clin Diagn Res. 2017;11:OD18-OD20.
    Abstract    

    Abstract available

  11. LIU D, Sindhu K, Witkin A, Patel L, et al
    Pulmonary Hypertension in a Patient with Hereditary Hemorrhagic Telangiectasia.
    R I Med J (2013). 2017;100:29-31.
    Abstract    

    Abstract available

  12. IVANOVSKA J, Shah S, Wong MJ, Kantores C, et al
    mTOR-Notch3 signaling mediates pulmonary hypertension in hypoxia-exposed neonatal rats independent of changes in autophagy.
    Pediatr Pulmonol. 2017 Jul 31. doi: 10.1002/ppul.23777.
    Abstract    

    Abstract available

  13. TRAWICKI MC, Volz LM
    Epidural for high-dose radiation brachytherapy in a noncompliant, super-obese patient with severe pulmonary hypertension.
    Saudi J Anaesth. 2017;11:343-345.
    Abstract    

    Abstract available

  14. JUNG C, Grun K, Betge S, Pernow J, et al
    Arginase Inhibition Reverses Monocrotaline-Induced Pulmonary Hypertension.
    Int J Mol Sci. 2017;18.
    Abstract    

    Abstract available

  15. TELO S, Kirkil G, Kuluozturk M, Balin M, et al
    Can ADMA play a role in determining pulmonary hypertension related to chronic obstructive pulmonary disease?
    Clin Respir J. 2017 Jul 29. doi: 10.1111/crj.12675.
    Abstract    

    Abstract available

  16. LI L, Kim IK, Chiasson V, Chatterjee P, et al
    NF-kappaB mediated miR-130a modulation in lung microvascular cell remodeling: Implication in pulmonary hypertension.
    Exp Cell Res. 2017 Jul 26. pii: S0014-4827(17)30397.
    Abstract    

    Abstract available

  17. GHATAORHE P, Rhodes CJ, Harbaum L, Attard M, et al
    Pulmonary arterial hypertension - progress in understanding the disease and prioritizing strategies for drug development.
    J Intern Med. 2017;282:129-141.
    Abstract    

    Abstract available

  18. LOONEY AP, Han R, Stawski L, Marden G, et al
    Synergistic Role of Endothelial ERG and FLI1 in Mediating Pulmonary Vascular Homeostasis.
    Am J Respir Cell Mol Biol. 2017;57:121-131.
    Abstract    

    Abstract available

  19. ARASZKIEWICZ A, Jankiewicz S, Lanocha M, Janus M, et al
    Optical coherence tomography improves the results of balloon pulmonary angioplasty in inoperable chronic thrombo-embolic pulmonary hypertension.
    Postepy Kardiol Interwencyjnej. 2017;13:180-181.
    Abstract    



  20. SAMAREH FEKRI M, Torabi M, Azizi Shoul S, Mirzaee M, et al
    Prevalence and predictors associated with severe pulmonary hypertension in COPD.
    Am J Emerg Med. 2017 Aug 5. pii: S0735-6757(17)30662.
    Abstract    

    Abstract available

  21. KOBAYASHI K, Suzuki M, Yamamoto S, Ueno K, et al
    Early-onset, Severe Chronic Obstructive Pulmonary Disease with Pulmonary Hypertension that was Likely Induced by Toluene Exposure.
    Intern Med. 2017 Aug 10. doi: 10.2169/internalmedicine.8077.
    Abstract    

    Abstract available

  22. YOO HHB, Dos Reis R, Telini WM, Telini LR, et al
    Association of Pulmonary Hypertension With Inflammation and Fluid Overload in Hemodialysis Patients.
    Iran J Kidney Dis. 2017;11:303-308.
    Abstract    

    Abstract available

  23. TAVARES-SILVA M, Alaa M, Leite S, Oliveira-Pinto J, et al
    Dose-Response Head-to-Head Comparison of Inodilators Dobutamine, Milrinone, and Levosimendan in Chronic Experimental Pulmonary Hypertension.
    J Cardiovasc Pharmacol Ther. 2017;22:485-495.
    Abstract    

    Abstract available

  24. LEE G, Lee J, Kim J, Choi HS, et al
    Single Microfluidic Electrochemical Sensor System for Simultaneous Multi-Pulmonary Hypertension Biomarker Analyses.
    Sci Rep. 2017;7:7545.
    Abstract    

    Abstract available

  25. HARTOPO AB, Dinarti LK, Wahab AS
    The Challenge in Diagnosis and Current Treatment of Chronic Thromboembolic Pulmonary Hypertension.
    Acta Med Indones. 2017;49:183-191.
    Abstract    

    Abstract available

  26. MATHEW B, Lakshminrusimha S
    Persistent Pulmonary Hypertension in the Newborn.
    Children (Basel). 2017;4.
    Abstract    

    Abstract available

  27. HSU CH, Roan JN, Wang JN, Huang CC, et al
    Hemodynamic, biological, and right ventricular functional changes following intraatrial shunt repair in patients with flow-induced pulmonary hypertension.
    Congenit Heart Dis. 2017;12:533-539.
    Abstract    

    Abstract available

  28. KOESTENBERGER M, Hansmann G
    Future Applications of the Selective Prostacyclin (IP) Receptor Agonist Selexipag in Pediatric Pulmonary Hypertension.
    Pediatr Cardiol. 2017 Aug 7. doi: 10.1007/s00246-017-1699.
    Abstract    



  29. YUM SK, Mi Seo Y, Kwun Y, Moon CJ, et al
    Therapeutic hypothermia in infants with hypoxic-ischemic encephalopathy and reversible persistent pulmonary hypertension: short-term hospital outcomes.
    J Matern Fetal Neonatal Med. 2017 Aug 7:1-13. doi: 10.1080/14767058.2017.1365123
    Abstract    

    Abstract available

  30. SETH SA, Soraisham AS, Harabor A
    Risk factors and outcomes of early pulmonary hypertension in preterm infants.
    J Matern Fetal Neonatal Med. 2017 Aug 7:1-17. doi: 10.1080/14767058.2017.1365129
    Abstract    

    Abstract available

  31. ZHANG Y, Wu S
    Effects of fasudil on pulmonary hypertension in clinical practice.
    Pulm Pharmacol Ther. 2017 Aug 4. pii: S1094-5539(17)30059.
    Abstract    

    Abstract available

  32. AKAGI S, Oto T, Kobayashi M, Miyoshi K, et al
    High Frequency of Acute Adverse Cardiovascular Events After Lung Transplantation in Patients With Pulmonary Arterial Hypertension Receiving Preoperative Long-Term Intravenous Prostacyclin.
    Int Heart J. 2017;58:557-561.
    Abstract    

    Abstract available


  33. [Twenty years experiences on the therapy of pulmonary artery hypertension: from classical diagnostics and treatment strategies to precision medicine].
    Zhonghua Xin Xue Guan Bing Za Zhi. 2017;45:476-479.
    Abstract    



  34. AUSTIN C, Burger C, Kane G, Safford R, et al
    High-risk echocardiographic features predict mortality in pulmonary arterial hypertension.
    Am Heart J. 2017;189:167-176.
    Abstract    

    Abstract available

  35. TOJAIS NF, Cao A, Lai YJ, Wang L, et al
    Codependence of Bone Morphogenetic Protein Receptor 2 and Transforming Growth Factor-beta in Elastic Fiber Assembly and Its Perturbation in Pulmonary Arterial Hypertension.
    Arterioscler Thromb Vasc Biol. 2017;37:1559-1569.
    Abstract    

    Abstract available

  36. MELOCHE J, Lampron MC, Nadeau V, Maltais M, et al
    Implication of Inflammation and Epigenetic Readers in Coronary Artery Remodeling in Patients With Pulmonary Arterial Hypertension.
    Arterioscler Thromb Vasc Biol. 2017 May 4. pii: ATVBAHA.117.309156.
    Abstract    

    Abstract available

  37. KIDO J, Mitsubuchi H, Sakanashi M, Matsubara J, et al
    Pulmonary artery hypertension in methylmalonic acidemia.
    Hemodial Int. 2017;21:E25-E29.
    Abstract    

    Abstract available

  38. JAMES MO, Jahn SC, Zhong G, Smeltz MG, et al
    Therapeutic applications of dichloroacetate and the role of glutathione transferase zeta-1.
    Pharmacol Ther. 2017;170:166-180.
    Abstract    

    Abstract available

  39. HOOD KY, Montezano AC, Harvey AP, Nilsen M, et al
    Nicotinamide Adenine Dinucleotide Phosphate Oxidase-Mediated Redox Signaling and Vascular Remodeling by 16alpha-Hydroxyestrone in Human Pulmonary Artery Cells: Implications in Pulmonary Arterial Hypertension.
    Hypertension. 2016 Jul 11. pii: HYPERTENSIONAHA.116.07668.
    Abstract    

    Abstract available

  40. DAWSON S, Lawrie A
    From bones to blood pressure, developing novel biologic approaches targeting the osteoprotegein pathway for pulmonary vascular disease.
    Pharmacol Ther. 2017;169:78-82.
    Abstract    

    Abstract available

  41. MULLIN CJ, Mathai SC
    New insights into the recognition, classification and management of systemic sclerosis-associated pulmonary hypertension.
    Curr Opin Rheumatol. 2017 Aug 16. doi: 10.1097/BOR.0000000000000440.
    Abstract    

    Abstract available

  42. ZHOU S, Sun L, Cao C, Wu P, et al
    Hypoxia-induced microRNA-26b inhibition contributes to hypoxic pulmonary hypertension via CTGF.
    J Cell Biochem. 2017 Aug 17. doi: 10.1002/jcb.26355.
    Abstract    

    Abstract available

  43. SCHINAGL C, Melum GR, Rodningen OK, Bjorgo K, et al
    Severe persistent pulmonary hypertension of the newborn and dysmorphic features in neonate with a deletion involving TWIST1 and PHF14: a case report.
    J Med Case Rep. 2017;11:226.
    Abstract    

    Abstract available

  44. KOMORI A, Ayusawa M, Kato M, Nakamura T, et al
    Congenital complete atrioventricular block with pulmonary hypertension.
    Pediatr Int. 2017 Aug 14. doi: 10.1111/ped.13347.
    Abstract    



  45. RICHTER MJ, Tello K, Milger K, Ghofrani HA, et al
    Tidal Carbon Dioxide as a Prognostic Feature in Inoperable Chronic Thromboembolic Pulmonary Hypertension.
    Ann Am Thorac Soc. 2017 Aug 14. doi: 10.1513/AnnalsATS.201704.
    Abstract    



  46. WELCH CE, Hemnes AR
    Reply: Tidal Carbon Dioxide as a Prognostic Feature in Inoperable Chronic Thromboembolic Pulmonary Hypertension.
    Ann Am Thorac Soc. 2017 Aug 14. doi: 10.1513/AnnalsATS.201707.
    Abstract    



  47. AVOUAC J, Guignabert C, Hoffmann-Vold AM, Ruiz B, et al
    Stromelysin-2 (MMP-10), a novel mediator of vascular remodeling underlying pulmonary hypertension associated with systemic sclerosis.
    Arthritis Rheumatol. 2017 Aug 13. doi: 10.1002/art.40229.
    Abstract    

    Abstract available

  48. SHINKURA Y, Nakayama K, Yanaka K, Kinutani H, et al
    Extensive revascularization by balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension beyond hemodynamic normalization.
    EuroIntervention. 2017 Aug 15. pii: EIJ-D-17-00157. doi: 10.4244/EIJ-D-17-00157.
    Abstract    

    Abstract available

  49. FEDERTI E, Matte' A, Ghigo A, Andolfo I, et al
    PEROXIREDOXIN-2 PLAYS A PIVOTAL ROLE AS MULTIMODAL CYTOPROTECTOR IN THE EARLY PHASE OF PULMONARY HYPERTENSION.
    Free Radic Biol Med. 2017 Aug 8. pii: S0891-5849(17)30720.
    Abstract    

    Abstract available

  50. BOULATE D, Ataam JA, Connolly AJ, Giraldeau G, et al
    Early Development of Right Ventricular Ischemic Lesions in a Novel Large Animal Model of Acute Right Heart Failure in Chronic Thromboembolic Pulmonary Hypertension.
    J Card Fail. 2017 Aug 8. pii: S1071-9164(17)31122.
    Abstract    

    Abstract available

  51. ATTAWAY AH, Myers C, Velani S, Schilz R, et al
    Inhaled Prostacyclin as Salvage Therapy for ARDS: Can We Find the Right Patient?
    Respir Care. 2017;62:1113-1115.
    Abstract    



  52. CHUNG HT, Chang YS, Liao SL, Lai SH, et al
    The effects of corrective surgery on endothelial biomarkers and anthropometric data in children with congenital heart disease.
    J Int Med Res. 2017;45:493-503.
    Abstract    

    Abstract available

  53. PAREKH D, Krajcer Z
    Patent ductus arteriosus and pulmonary arterial hypertension: Is it closer to closure?
    Catheter Cardiovasc Interv. 2017;89:726-727.
    Abstract    



  54. TIMOTEO AT
    Bendopnea: A new symptom for the differential diagnosis of chronic cardiopulmonary disease?
    Rev Port Cardiol. 2017;36:187-188.
    Abstract    



  55. HAO Y, Hudson M, Baron M, Carreira P, et al
    Early Mortality in a Multinational Systemic Sclerosis Inception Cohort.
    Arthritis Rheumatol. 2017;69:1067-1077.
    Abstract    

    Abstract available

  56. D'ALTO M, Romeo E, Argiento P, Pavelescu A, et al
    A simple echocardiographic score for the diagnosis of pulmonary vascular disease in heart failure.
    J Cardiovasc Med (Hagerstown). 2017;18:237-243.
    Abstract    

    Abstract available

  57. KUSUNOSE K, Yamada H, Nishio S, Hirata Y, et al
    Echocardiographic Predictors for Worsening of Six-Minute Walk Distances in Patients With Systemic Sclerosis (Scleroderma).
    Am J Cardiol. 2017;120:315-321.
    Abstract    

    Abstract available

  58. AGARWAL M, Agrawal S, Garg L, Lavie CJ, et al
    Relation Between Obesity and Survival in Patients Hospitalized for Pulmonary Arterial Hypertension (from a Nationwide Inpatient Sample Database 2003 to 2011).
    Am J Cardiol. 2017 May 11. pii: S0002-9149(17)30788.
    Abstract    

    Abstract available

  59. PENUMATSA KC, Toksoz D, Warburton RR, Kharnaf M, et al
    Transglutaminase 2 in Pulmonary and Cardiac Tissue Remodeling in Experimental Pulmonary Hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2017 Aug 3:ajplung.00170.2017.
    Abstract    

    Abstract available

  60. CAI P, Kovacs L, Dong S, Wu G, et al
    BMP4 inhibits PDGF-induced proliferation and collagen synthesis via PKA-mediated inhibition of calpain-2 in pulmonary artery smooth muscle cells.
    Am J Physiol Lung Cell Mol Physiol. 2017;312:L638-L648.
    Abstract    

    Abstract available

  61. SCHREIBER C, Eilenberg MS, Kiss A, Bergmeister H, et al
    PRESERVED RIGHT VENTRICULAR INTEGRITY IN A NEW TELEMETRIC RAT MODEL OF SEVERE PULMONARY HYPERTENSION.
    Am J Physiol Lung Cell Mol Physiol. 2017 Aug 10:ajplung.00278.2017.
    Abstract    

    Abstract available

  62. NEWMAN JH, Rich S, Abman SH, Alexander JH, et al
    Enhancing Insights into Pulmonary Vascular Disease through a Precision Medicine Approach. A Joint NHLBI-Cardiovascular Medical Research and Education Fund Workshop Report.
    Am J Respir Crit Care Med. 2017;195:1661-1670.
    Abstract    

    Abstract available

  63. SWIFT AJ, Capener D, Johns C, Hamilton N, et al
    Magnetic Resonance Imaging in the Prognostic Evaluation of Patients with Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2017;196:228-239.
    Abstract    

    Abstract available

  64. ZIJLSTRA WMH, Ploegstra MJ, Vissia-Kazemier T, Roofthooft MTR, et al
    Physical Activity in Pediatric Pulmonary Arterial Hypertension Measured by Accelerometry. A Candidate Clinical Endpoint.
    Am J Respir Crit Care Med. 2017;196:220-227.
    Abstract    

    Abstract available

  65. KAWUT SM, Archer-Chicko CL, DeMichele A, Fritz JS, et al
    Anastrozole in Pulmonary Arterial Hypertension. A Randomized, Double-Blind, Placebo-controlled Trial.
    Am J Respir Crit Care Med. 2017;195:360-368.
    Abstract    

    Abstract available

  66. HONG Z, Chen KH, DasGupta A, Potus F, et al
    MicroRNA-138 and MicroRNA-25 Down-regulate Mitochondrial Calcium Uniporter, Causing the Pulmonary Arterial Hypertension Cancer Phenotype.
    Am J Respir Crit Care Med. 2017;195:515-529.
    Abstract    

    Abstract available

  67. QIN G, Luo H, Yin X, Wang L, et al
    Effects of Sevoflurane on Hemodynamics and Inducible Nitric Oxide Synthase/Soluble Guanylate Cyclase Signaling Pathway in a Rat Model of Pulmonary Arterial Hypertension.
    Anesth Analg. 2017;125:184-189.
    Abstract    

    Abstract available

  68. AVOUAC J, Konstantinova I, Guignabert C, Pezet S, et al
    Pan-PPAR agonist IVA337 is effective in experimental lung fibrosis and pulmonary hypertension.
    Ann Rheum Dis. 2017 Aug 11. pii: annrheumdis-2016-210821.
    Abstract    

    Abstract available

  69. GOMBERG-MAITLAND M, Souza R
    Uncovering Small Secrets in Big Data Sets: How Math Can Identify Biology in Rare Conditions (Pediatric Pulmonary Hypertension).
    Circ Res. 2017;121:317-319.
    Abstract    



  70. WONG HS, Williams AJ, Mok Y
    The relationship between pulmonary hypertension and obstructive sleep apnea.
    Curr Opin Pulm Med. 2017 Aug 3. doi: 10.1097/MCP.0000000000000421.
    Abstract    

    Abstract available

  71. HOEPER MM, Kramer T, Pan Z, Eichstaedt CA, et al
    Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model.
    Eur Respir J. 2017;50.
    Abstract    

    Abstract available

  72. DUMITRESCU D, Nagel C, Kovacs G, Bollmann T, et al
    Cardiopulmonary exercise testing for detecting pulmonary arterial hypertension in systemic sclerosis.
    Heart. 2017;103:774-782.
    Abstract    

    Abstract available

  73. ZIJLSTRA WM, Elmasry O, Pepplinkhuizen S, Ivy DD, et al
    Pulmonary arterial hypertension in children after neonatal arterial switch operation.
    Heart. 2017;103:1244-1249.
    Abstract    

    Abstract available

  74. GALIE N, Saia F, Palazzini M, Manes A, et al
    Left Main Coronary Artery Compression in Patients With Pulmonary Arterial Hypertension and Angina.
    J Am Coll Cardiol. 2017;69:2808-2817.
    Abstract    

    Abstract available

  75. TOYAMA H, Takei Y, Saito K, Mori S, et al
    Ventricular Assist Device Implantation in a Patient With Severe Systemic Right Ventricular Failure and Pulmonary Hypertension Secondary to Congenitally Corrected Transposition of Great Arteries.
    J Cardiothorac Vasc Anesth. 2017 Apr 6. pii: S1053-0770(17)30362.
    Abstract    



  76. HARGRAVE J
    Con: Preinduction Pulmonary Artery Catheter Placement Is Advisable in Patients With Right Ventricular Dysfunction Secondary to Severe Pulmonary Hypertension.
    J Cardiothorac Vasc Anesth. 2017;31:1514-1518.
    Abstract    



  77. FUJIMOTO Y, Urashima T, Kawachi F, Akaike T, et al
    Pulmonary hypertension due to left heart disease causes intrapulmonary venous arterialization in rats.
    J Thorac Cardiovasc Surg. 2017 Jul 5. pii: S0022-5223(17)31372.
    Abstract    

    Abstract available

  78. BUJAK R, Mateo J, Blanco I, Izquierdo-Garcia JL, et al
    New Biochemical Insights into the Mechanisms of Pulmonary Arterial Hypertension in Humans.
    PLoS One. 2016;11:e0160505.
    Abstract    

    Abstract available

  79. PEREZ M, Lee KJ, Cardona HJ, Taylor JM, et al
    Aberrant cGMP signaling persists during recovery in mice with oxygen-induced pulmonary hypertension.
    PLoS One. 2017;12:e0180957.
    Abstract    

    Abstract available

  80. SZEMA AM, Forsyth E, Ying B, Hamidi SA, et al
    NFATc3 and VIP in Idiopathic Pulmonary Fibrosis and Chronic Obstructive Pulmonary Disease.
    PLoS One. 2017;12:e0170606.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;